Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients L Quagliata, MS Matter, S Piscuoglio, L Arabi, C Ruiz, A Procino, M Kovac, ... Hepatology 59 (3), 911-923, 2014 | 459 | 2014 |
Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire M Lepore, A Kalinichenko, A Colone, B Paleja, A Singhal, A Tschumi, ... Nature communications 5 (1), 3866, 2014 | 350 | 2014 |
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer F Crea, A Watahiki, L Quagliata, H Xue, L Pikor, A Parolia, Y Wang, D Lin, ... Oncotarget 5 (3), 764, 2014 | 247 | 2014 |
The protein histidine phosphatase LHPP is a tumour suppressor SK Hindupur, M Colombi, SR Fuhs, MS Matter, Y Guri, K Adam, M Cornu, ... Nature 555 (7698), 678-682, 2018 | 206 | 2018 |
Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment E Horwitz, I Stein, M Andreozzi, J Nemeth, A Shoham, O Pappo, ... Cancer discovery 4 (6), 730-743, 2014 | 199 | 2014 |
A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4 MT Hansen, B Forst, N Cremers, L Quagliata, N Ambartsumian, ... Oncogene 34 (4), 424-435, 2015 | 169 | 2015 |
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21 M Cornu, W Oppliger, V Albert, AM Robitaille, F Trapani, L Quagliata, ... Proceedings of the National Academy of Sciences 111 (32), 11592-11599, 2014 | 160 | 2014 |
Cancer diagnosis using a liquid biopsy: challenges and expectations F Castro-Giner, S Gkountela, C Donato, I Alborelli, L Quagliata, CKY Ng, ... Diagnostics 8 (2), 31, 2018 | 133 | 2018 |
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study I Alborelli, D Generali, P Jermann, MR Cappelletti, G Ferrero, ... Cell death & disease 10 (7), 534, 2019 | 124 | 2019 |
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer I Alborelli, K Leonards, SI Rothschild, LP Leuenberger, S Savic Prince, ... The Journal of pathology 250 (1), 19-29, 2020 | 116 | 2020 |
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis P Zavattari, A Perra, S Menegon, MA Kowalik, A Petrelli, MM Angioni, ... Hepatology 62 (3), 851-862, 2015 | 105 | 2015 |
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study CKY Ng, GG Di Costanzo, N Tosti, V Paradiso, M Coto-Llerena, ... Annals of Oncology 29 (5), 1286-1291, 2018 | 94 | 2018 |
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis MA Kowalik, G Guzzo, A Morandi, A Perra, S Menegon, I Masgras, ... Oncotarget 7 (22), 32375, 2016 | 94 | 2016 |
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers P Carotenuto, M Fassan, R Pandolfo, A Lampis, C Vicentini, L Cascione, ... Gut 66 (7), 1268-1277, 2017 | 92 | 2017 |
Variable asialoglycoprotein receptor 1 expression in liver disease: Implications for therapeutic intervention D Witzigmann, L Quagliata, SH Schenk, C Quintavalle, LM Terracciano, ... Hepatology Research 46 (7), 686-696, 2016 | 89 | 2016 |
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome‐based molecular classifications of hepatocellular carcinoma Z Makowska, T Boldanova, D Adametz, L Quagliata, JE Vogt, MT Dill, ... The Journal of Pathology: Clinical Research 2 (2), 80-92, 2016 | 78 | 2016 |
Ofd1 is required in limb bud patterning and endochondral bone development S Bimonte, A De Angelis, L Quagliata, F Giusti, R Tammaro, R Dallai, ... Developmental biology 349 (2), 179-191, 2011 | 75 | 2011 |
Syrosingopine sensitizes cancer cells to killing by metformin D Benjamin, M Colombi, SK Hindupur, C Betz, HA Lane, ... Science advances 2 (12), e1601756, 2016 | 71 | 2016 |
Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient E Dazert, M Colombi, T Boldanova, S Moes, D Adametz, L Quagliata, ... Proceedings of the National Academy of Sciences 113 (5), 1381-1386, 2016 | 71 | 2016 |
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression F Crea, L Quagliata, A Michael, HH Liu, P Frumento, AA Azad, H Xue, ... Molecular oncology 10 (5), 693-703, 2016 | 67 | 2016 |